+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Fertility Drugs Global Market Report 2022, Gender, Route of Administration, Type Of Drug, Distribution Channel

  • PDF Icon

    Report

  • 175 Pages
  • March 2022
  • Region: Global
  • The Business Research Company
  • ID: 5559817
Fertility Drugs Global Market Report 2022 provides the strategists, marketers and senior management with the critical information they need to assess the global fertility drugs market as it emerges from the Covid 19 shut down.



Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis

Description:


Where is the largest and fastest growing market for the fertility drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Fertility Drugs market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider fertility drugs market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the Covid 19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The fertility drugs market section of the report gives context. It compares the fertility drugs market with other segments of the fertility drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, fertility drugs indicators comparison.

Scope


Markets Covered:
1) By Gender: Male; Female
2) By Route of Administration: Oral; Intravenous; Subcutaneous; Intramuscular
3) By Type Of Drug: Prescription Fertility Drugs; Over-The-Counter Fertility drugs
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies

Companies Mentioned: Merck & Co.; Ferring Pharmaceuticals; Bayer; Berlex Laboratories Inc.; Janssen Pharmaceutical Inc.

Countries: Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA; Australia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, per capita expenditure.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.


This product will be delivered within 1-3 business days.
Frequently Asked Questions about the Global Fertility Drugs Market

What is the estimated value of the Global Fertility Drugs Market?

The Global Fertility Drugs Market was estimated to be valued at $2.92 billion in 2022.

What is the growth rate of the Global Fertility Drugs Market?

The growth rate of the Global Fertility Drugs Market is 3.9%, with an estimated value of $3.4 billion by 2026.

What is the forecasted size of the Global Fertility Drugs Market?

The Global Fertility Drugs Market is estimated to be worth $3.4 billion by 2026.

Who are the key companies in the Global Fertility Drugs Market?

Key companies in the Global Fertility Drugs Market include Merck & Co., Ferring Pharmaceuticals, Bayer, Berlex Laboratories Inc., Janssen Pharmaceutical Inc., Pfizer, Novartis AG, Procter & Gamble Pharmaceutical and LIVZON.

Table of Contents

1. Executive Summary2. Fertility Drugs Market Characteristics3. Fertility Drugs Market Trends And Strategies4. Impact Of COVID-19 On Fertility Drugs
5. Fertility Drugs Market Size And Growth
5.1. Global Fertility Drugs Historic Market, 2016-2021, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Fertility Drugs Forecast Market, 2021-2026F, 2031F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market
6. Fertility Drugs Market Segmentation
6.1. Global Fertility Drugs Market, Segmentation By Gender, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Male
  • Female
6.2. Global Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Oral
  • Intravenous
  • Subcutaneous
  • Intramuscular
6.3. Global Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Prescription Fertility Drugs
  • Over-The-Counter Fertility drugs
6.4. Global Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

7. Fertility Drugs Market Regional And Country Analysis
7.1. Global Fertility Drugs Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
7.2. Global Fertility Drugs Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
8. Asia-Pacific Fertility Drugs Market
8.1. Asia-Pacific Fertility Drugs Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Fertility Drugs Market, Segmentation By Gender, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
8.3. Asia-Pacific Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
9. China Fertility Drugs Market
9.1. China Fertility Drugs Market Overview
9.2. China Fertility Drugs Market, Segmentation By Gender, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion
9.3. China Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion
10. India Fertility Drugs Market
10.1. India Fertility Drugs Market, Segmentation By Gender, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
10.2. India Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
11. Japan Fertility Drugs Market
11.1. Japan Fertility Drugs Market, Segmentation By Gender, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
11.2. Japan Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
12. Australia Fertility Drugs Market
12.1. Australia Fertility Drugs Market, Segmentation By Gender, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
12.2. Australia Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
13. Indonesia Fertility Drugs Market
13.1. Indonesia Fertility Drugs Market, Segmentation By Gender, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
13.2. Indonesia Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
14. South Korea Fertility Drugs Market
14.1. South Korea Fertility Drugs Market, Segmentation By Gender, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
14.2. South Korea Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
15. Western Europe Fertility Drugs Market
15.1. Western Europe Fertility Drugs Market Overview
15.2. Western Europe Fertility Drugs Market, Segmentation By Gender, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
15.3. Western Europe Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
16. UK Fertility Drugs Market
16.1. UK Fertility Drugs Market, Segmentation By Gender, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
16.2. UK Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
17. Germany Fertility Drugs Market
17.1. Germany Fertility Drugs Market, Segmentation By Gender, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
17.2. Germany Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
18. France Fertility Drugs Market
18.4. France Fertility Drugs Market, Segmentation By Gender, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
18.5. France Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
19. Eastern Europe Fertility Drugs Market
19.1. Eastern Europe Fertility Drugs Market Overview
19.2. Eastern Europe Fertility Drugs Market, Segmentation By Gender, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
19.3. Eastern Europe Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
20. Russia Fertility Drugs Market
20.1. Russia Fertility Drugs Market, Segmentation By Gender, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
20.2. Russia Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
21. North America Fertility Drugs Market
21.1. North America Fertility Drugs Market Overview
21.2. North America Fertility Drugs Market, Segmentation By Gender, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
21.3. North America Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
22. USA Fertility Drugs Market
22.1. USA Fertility Drugs Market Overview
22.2. USA Fertility Drugs Market, Segmentation By Gender, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
22.3. USA Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
23. South America Fertility Drugs Market
23.1. South America Fertility Drugs Market Overview
23.2. South America Fertility Drugs Market, Segmentation By Gender, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
23.3. South America Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
24. Brazil Fertility Drugs Market
24.1. Brazil Fertility Drugs Market, Segmentation By Gender, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
24.2. Brazil Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
25. Middle East Fertility Drugs Market
25.1. Middle East Fertility Drugs Market Overview
25.2. Middle East Fertility Drugs Market, Segmentation By Gender, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
25.3. Middle East Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
26. Africa Fertility Drugs Market
26.1. Africa Fertility Drugs Market Overview
26.2. Africa Fertility Drugs Market, Segmentation By Gender, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
26.3. Africa Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
27. Fertility Drugs Market Competitive Landscape And Company Profiles
27.1. Fertility Drugs Market Competitive Landscape
27.2. Fertility Drugs Market Company Profiles
27.2.1. Merck & Co.
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Ferring Pharmaceuticals
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Bayer
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Berlex Laboratories Inc.
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Janssen Pharmaceutical Inc.
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance
28. Fertility Drugs Pipeline Analysis29. Key Mergers And Acquisitions In The Fertility Drugs Market30. Fertility Drugs Market Future Outlook and Potential Analysis
31. Appendix
31.1. Abbreviations
31.2. Currencies
31.3. Research Inquiries
31.4. About the Publisher
31.5. Copyright And Disclaimer

Executive Summary

Major players in the fertility drugs market are Merck & Co., Ferring Pharmaceuticals, Bayer, Berlex Laboratories Inc., Janssen Pharmaceutical Inc., Pfizer, Novartis AG, Procter & Gamble Pharmaceutical, Zydus Pharma, LIVZON, Abbott, MSD, Sanofi S.A., Eli Lilly and Co., Serono, Inc., Novogyne Pharmaceuticals and Takeda Pharmaceutical co. ltd.

The global fertility drugs market is expected to grow from $2.77 billion in 2021 to $2.92 billion in 2022 at a compound annual growth rate (CAGR) of 5.4%. The growth is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $3.40 billion in 2026 at a CAGR of 3.9%.

The fertility drugs market consists of sales of fertility drugs and related services used to aid the production of sperms and eggs in order to promote fertility among men and women. Fertility drugs are the primary treatment for infertility and increase the chances of producing an offspring by stimulating and regulating ovulation in women and increasing the sperm count in men.

The main types of fertility drugs are prescription fertility drugs and over-the-counter fertility drugs. The drugs are administered through oral, intravenous, subcutaneous and intramuscular to male and female patients. Subcutaneous administration refers to the process of injecting the drugs in the fatty tissue just beneath the skin. The drugs are distributed through hospital pharmacies, retail pharmacies and online pharmacies.

North America was the largest region in the fertility drugs market in 2021. Middle East is expected to be the fargest growing region in the forecast period. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The growth of the fertility drugs market is driven by the increasing rates of infertility across the globe. Infertility is the inability to conceive after trying for 12 consecutive months. Fertility drugs are considered to be the primary treatment to treat infertility in men and women. The rising rates of infertility is attributed to physiological problems, hormone problems, and lifestyle or environmental factors. To treat infertility problems in women, fertility drugs are used to regulate their ovulation cycles thus affecting the sale of fertility drugs. According to the Centers for Disease Control and Prevention (CDC) in 2019, infertility affects 10% of women between the ages of 15 and 44 in the US. Further, in 2019, in India, 10% to 15% of couples in reproductive age group are suffering from infertility. Hence, the rising cases of infertility across the globe is increasing the demand for fertility drugs, resulting in the growth of fertility drugs market.

The side effects caused due to fertility drugs restricted the growth of the fertility drugs market. Fertility drugs can result in permanent as well as temporary side effects. Temporary side effects includes bloating, headache, breast tenderness, upset stomach, hot flashes, and mood swings whereas the permanent side effects includes multiple pregnancies, ovarian hyperstimulation syndrome (OHSS). OHSS is a condition where the ovaries enlarge with fluids and may become life threating if left untreated. For instance, the intake of Clomid (clomiphene citrate), a fertility drug for women, can result in OHSS along with abnormal vaginal/uterine bleeding, breast tenderness or discomfort, headache, nausea, vomiting, diarrhoea, flushing, blurred vision or other visual disturbances. The fear of potential side effects of the fertility drugs restrict the growth of the fertility drugs market.

In 2019, Ferring Pharmaceuticals, a USA based biopharmaceutical company, acquired USA commercialization rights of Ganirelix Acetate Injection from Sun Pharmaceutical Industries Ltd for an amount undisclosed. Through the acquisition, Ferring Pharmaceutical aims to broaden its medicine portfolio targeted towards reproduction. Ganirelix Acetate Injection was approved by FDA in 2018 and is used to regulate premature luteinizing hormone (LH) levels in women undergoing fertility treatment. The Sun Pharmaceutical Industries Ltd is an India based manufacturer and seller of pharmaceutical formulations and active pharmaceutical ingredients.

The countries covered in the fertility drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Merck & Co.
  • Ferring Pharmaceuticals
  • Bayer
  • Berlex Laboratories Inc.
  • Janssen Pharmaceutical Inc.
  • Pfizer
  • Novartis AG
  • Procter & Gamble Pharmaceutical
  • Zydus Pharma
  • LIVZON
  • Abbott
  • MSD
  • Sanofi S.A.
  • Eli Lilly and Co.
  • Serono, Inc.
  • Novogyne Pharmaceuticals
  • Takeda Pharmaceutical co. ltd.

Methodology

Loading
LOADING...